Publication Name	World Journal of Clinical Oncology
Manuscript ID	2697
Country	United States

Received	2013-03-07 20:33
Peer-Review Started	2013-03-08 11:07
To Make the First Decision	2013-03-26 11:25
Return for Revision	2013-04-01 10:02
Revised	2013-04-04 09:49
Second Decision	2013-04-17 10:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-04-17 11:14
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-05-10 09:57
Publish the Manuscript Online	2013-05-20 09:37

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma
Manuscript Source	Invited Manuscript
All Author List	Soley Bayraktar and Caio M Rocha-Lima
Funding Agency and Grant Number
Corresponding Author	Soley Bayraktar, MD, MBA, Departments of Medical Oncology, Mercy Cancer Center, 1220 Hall street, Ardmore, OK 73401, United States. soley.bayraktar@mercy.net
Key Words	Non-small cell lung cancer; Molecular targeted therapy; Vascular endothelial growth factor; Epidermal growth factor receptor; Tyrosine kinase inhibitors; BRAF; Anaplastic lymphoma kinase
Core Tip	Targetable molecular abnormalities have not yet been identified in approximately 80% of non-small-cell lung cancer patients. In addition to anaplastic lymphoma kinase, epidermal growth factor receptor, vascular endothelial growth factor targeted therapies, the results from ongoing trials will determine if the newer targeted agents will be incorporated into clinical practice.
Publish Date	2013-05-20 09:37
Citation	Bayraktar S, Rocha-Lima CM. Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma. World J Clin Oncol 2013; 4(2): 29-42
URL	http://www.wjgnet.com/2218-4333/full/v4/i2/29.htm
DOI	http://dx.doi.org/10.5306/wjco.v4.i2.29

Full Article (PDF)	WJCO-4-29.pdf
Manuscript File	2697-Review.doc
Answering Reviewers	2697-Answering reviewers.docx
Copyright License Agreement	2697-Copyright assignment.pdf
Peer-review Report	2697-Peer review(s).pdf
Scientific Editor Work List	2697-Scientific editor work list.doc